Hall & Partners promotes Sue Klinck to global people roleHall & Partners has promoted Sue Klinck to the newly-created role of global head of people and culture. Share XHall & Partners promotes Sue Klinck to global people rolehttps://pharmaphorum.com/news/hall-partners-sue-klinck/
Drugs could mimic gut bacteria benefits to treat diabetesIt may be possible to design drugs that mimic the positive health benefits of gut bacteria to treat Share XDrugs could mimic gut bacteria benefits to treat diabeteshttps://pharmaphorum.com/news/drugs-gut-bacteria-diabetes/
Novartis files potential blockbuster eye drug with FDANovartis has filed its ophthalmology drug brolucizumab with the US regulator, a potentially strong competitor in the tough Share XNovartis files potential blockbuster eye drug with FDAhttps://pharmaphorum.com/news/novartis-files-potential-blockbuster-eye-drug/
Clovis hit by bladder cancer fail for RubracaClovis Oncology’s hopes of a carving out a niche for its PARP inhibitor Rubraca in bladder cancer, away Share XClovis hit by bladder cancer fail for Rubracahttps://pharmaphorum.com/news/clovis-hit-by-bladder-cancer-fail-for-rubraca/
Amazon steps up Alexa’s healthcare information skillsAmazon’s healthcare ambitions for Alexa took a big step forward this month with the announcement that its smart Share XAmazon steps up Alexa’s healthcare information skillshttps://pharmaphorum.com/digital/amazon-alexa-healthcare-skills/
European regulator restricts use of Sanofi MS drug LemtradaThe European drug regulator has called for a review of Sanofi’s multiple sclerosis drug Lemtrada following reports of Share XEuropean regulator restricts use of Sanofi MS drug Lemtradahttps://pharmaphorum.com/news/european-regulator-restricts-use-of-sanofi-ms-drug-lemtrada/
Medbelle to expand UK ‘digital hospital’ following cash boostUK-based Medbelle has said it will expand its “digital hospital” service that aims to help patients navigate their Share XMedbelle to expand UK ‘digital hospital’ following cash boosthttps://pharmaphorum.com/news/medbelle-to-expand-uk-digital-hospital-following-cash-boost/
Alnylam to file gene-silencing porphyria drugAlnylam is to file its givosiran with regulators to treat a form of the blood disease porphyria, applying Share XAlnylam to file gene-silencing porphyria drughttps://pharmaphorum.com/news/alnylam-to-file-gene-silencing-porphyria-drug/
FDA approves PureTech’s obesity device PlenityThe FDA has approved PureTech Health’s ‘space occupying’ device Plenity as a new prescription treatment for obesity, setting Share XFDA approves PureTech’s obesity device Plenityhttps://pharmaphorum.com/news/fda-approves-puretech-obesity-plenity/
